1. Home
  2. LZB vs PVLA Comparison

LZB vs PVLA Comparison

Compare LZB & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$39.63

Market Cap

1.5B

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$145.21

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZB
PVLA
Founded
1927
2015
Country
United States
United States
Employees
N/A
29
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
LZB
PVLA
Price
$39.63
$145.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
15
Target Price
$39.00
$171.87
AVG Volume (30 Days)
743.9K
324.0K
Earning Date
06-16-2026
05-12-2026
Dividend Yield
2.75%
N/A
EPS Growth
5.11
N/A
EPS
2.47
N/A
Revenue
$2,349,433,000.00
N/A
Revenue This Year
$1.89
N/A
Revenue Next Year
$2.09
$104,350.18
P/E Ratio
$16.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.03
$23.86
52 Week High
$44.90
$161.38

Technical Indicators

Market Signals
Indicator
LZB
PVLA
Relative Strength Index (RSI) 55.66 63.97
Support Level $36.31 $106.07
Resistance Level $39.76 $151.18
Average True Range (ATR) 1.73 8.09
MACD -0.01 4.47
Stochastic Oscillator 46.29 70.09

Price Performance

Historical Comparison
LZB
PVLA

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: